Future-Ready Pharmacovigilance: Geographies, Advanced Therapies, and Emerging Risks

About this session

Programme: PV.S2.T1: Comparative Safety Profile of Lutetium-177 Radioligand Therapies; PV.S2.T2: Strengthening Pharmacovigilance in SAARC LMICs – Lessons from Africa and India; PV.S2.T3: Panel Discussion: Next-Generation Drug Safety: Managing Risks in a Rapidly Changing Therapeutic Landscape.

Speakers

• 

  Prantika Khetarpal

  Pharmacovigilance Industry Leader, Business Process Services Life Sciences · Tata Consultancy Services Limited (TCS)

  Chair

• 

  Vidisha Vivek Parulekar

  Senior Physician, Patient Safety · Parexel

  Speaker

• 

  Retesh Bhumbak

  World Wide Patient Safety Site Head · Bristol Myers Squibb (BMS)

  Speaker

• 

  Shahnawaz Ibrahim

  Head - Pharmacovigilance & Medical Information Operations · Lupin Limited

  Speaker

• 

  Anuja Jawale

  Associate Director, Area Safety Head · Kenvue

  Speaker

• 

  Deepa Arora

  Chief Executive Officer · CLINEXEL

  Speaker